HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of a rodent peroxisome proliferator in two species of freshwater fish: rainbow trout (Onchorynchus mykiss) and Japanese medaka (Oryzias latipes)

Abstract
Rainbow trout (Onchorynchus mykiss) and Japanese medaka (Oryzias latipes) were exposed to the hypolipidemic drug gemfibrozil, a known rodent peroxisome proliferator. Trout were injected (i.p.) daily for 2 weeks at doses of 0, 46, 87, or 152 mg/kg/day. Medaka were exposed to the nominal concentrations of 0, 1.25, 2.5, or 5 ppm in water for 2 weeks in a static-renewal system. Peroxisome proliferation was assessed by measuring fatty acyl-CoA oxidase (FAO) activity, peroxisomal bifunctional enzyme (PBE) quantity, and changes in liver-to-body weight ratios (LWR). Results indicate that a mild peroxisome proliferative response was observed in rainbow trout (significant increases in FAO activity at all dose levels and in LWR at the highest dose level). Medaka demonstrated a significant increase in PBE at the highest dose level, while nonsignificant increases in FAO activity were observed at the mid- and high-dose levels.
AuthorsL J Scarano, E J Calabrese, P T Kostecki, L A Baldwin, D A Leonard
JournalEcotoxicology and environmental safety (Ecotoxicol Environ Saf) Vol. 29 Issue 1 Pg. 13-9 (Oct 1994) ISSN: 0147-6513 [Print] Netherlands
PMID7529160 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Water Pollutants, Chemical
  • Gemfibrozil
Topics
  • Animals
  • Body Weight (drug effects)
  • Female
  • Gemfibrozil (pharmacology)
  • Injections, Intraperitoneal
  • Liver (drug effects)
  • Male
  • Microbodies (drug effects, physiology)
  • Oncorhynchus mykiss
  • Organ Size (drug effects)
  • Oryzias
  • Rodentia
  • Water Pollutants, Chemical (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: